Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polycythemia vera.

Brian J Stuart1, Anthony J Viera

  • 1Naval Hospital Jacksonville, Family Practice Department, Jacksonville, Florida 32214, USA. stuartbj@2fssg.usmc.mil

American Family Physician
|May 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral microbiome alpha diversity and all-cause, cardiovascular, and non-cardiovascular mortality in US adults: Evidence from the NHANES 2009-2019.

Atherosclerosis·2024
Same author

Use of Impedance Cardiography to Guide Blood Pressure Lowering Medication Selection: Systematic Review of Randomized Controlled Trials.

American journal of hypertension·2024
Same author

The utility of home blood pressure load in predicting average self-measured blood pressure.

Journal of hypertension·2024
Same author

Who chooses "healthy" meals? An analysis of lunchtime meal quality in a workplace cafeteria.

BMC public health·2024
Same author

The eProvider Model: A Novel Approach to the Modern Problem of Portal Message Overload.

Family practice management·2024
Same author

Sex Differences in Receipt of Bystander Cardiopulmonary Resuscitation Considering Neighborhood Racial and Ethnic Composition.

Journal of the American Heart Association·2024
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026
See all related articles

Polycythemia vera, a blood disorder causing high red blood cell mass, increases thrombosis risk. Early diagnosis and treatment, including phlebotomy and myelosuppressants, significantly improve patient survival and quality of life.

Area of Science:

  • Hematology
  • Oncology

Background:

  • Polycythemia vera is a chronic myeloproliferative neoplasm.
  • It is characterized by an overproduction of red blood cells, leading to hyperviscosity and thrombosis.
  • Secondary causes of erythrocytosis must be excluded before diagnosis.

Purpose of the Study:

  • To outline the diagnostic criteria for Polycythemia vera.
  • To discuss the clinical presentation and complications.
  • To review current and investigational treatment strategies.

Main Methods:

  • Diagnosis relies on criteria from the Polycythemia Vera Study Group.
  • Key diagnostic indicators include elevated red blood cell mass and splenomegaly.
  • Exclusion of secondary causes is critical.

Related Experiment Videos

Main Results:

  • Untreated Polycythemia vera has a poor prognosis (6-18 months survival).
  • Effective treatment can extend life expectancy to over 10 years.
  • Phlebotomy is a primary treatment, often combined with myelosuppressive agents.

Conclusions:

  • Polycythemia vera requires prompt diagnosis and management.
  • Risk-stratified treatment approaches improve outcomes.
  • Ongoing research explores novel therapeutic agents like interferon alfa-2b, anagrelide, and aspirin.